Denis Caillot

1992–2025 年に発表

116
論文数
23,404
被引用数
78
h 指数
114
i10 指数

被引用数

Denis Caillot の年別被引用数1948 年: 被引用 1 件1988 年: 被引用 1 件1993 年: 被引用 3 件1994 年: 被引用 1 件1995 年: 被引用 3 件1996 年: 被引用 15 件1997 年: 被引用 3 件1998 年: 被引用 9 件1999 年: 被引用 17 件2000 年: 被引用 26 件2001 年: 被引用 34 件2002 年: 被引用 45 件2003 年: 被引用 108 件2004 年: 被引用 108 件2005 年: 被引用 111 件2006 年: 被引用 135 件2007 年: 被引用 154 件2008 年: 被引用 154 件2009 年: 被引用 160 件2010 年: 被引用 135 件2011 年: 被引用 176 件2012 年: 被引用 133 件2013 年: 被引用 149 件2014 年: 被引用 137 件2015 年: 被引用 135 件2016 年: 被引用 138 件2017 年: 被引用 181 件2018 年: 被引用 125 件2019 年: 被引用 522 件2020 年: 被引用 664 件2021 年: 被引用 719 件2022 年: 被引用 520 件2023 年: 被引用 388 件2024 年: 被引用 582 件2025 年: 被引用 241 件2026 年: 被引用 3 件1949〜1987 年は被引用が無いため表示していません1989〜1992 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,014 件、この内訳の 23.8%フランス: 引用元論文 731 件、この内訳の 8.7%ドイツ: 引用元論文 542 件、この内訳の 6.4%イギリス: 引用元論文 519 件、この内訳の 6.1%イタリア: 引用元論文 517 件、この内訳の 6.1%スペイン: 引用元論文 404 件、この内訳の 4.8%オランダ: 引用元論文 354 件、この内訳の 4.2%中国: 引用元論文 317 件、この内訳の 3.8%カナダ: 引用元論文 279 件、この内訳の 3.3%オーストラリア: 引用元論文 230 件、この内訳の 2.7%ギリシャ: 引用元論文 208 件、この内訳の 2.5%ベルギー: 引用元論文 206 件、この内訳の 2.4%
0%23.8%その他 25.2%

分野

  • Medicine88.9%
  • Biochemistry, Genetics and Molecular Biology7.4%
  • Immunology and Microbiology1.9%
  • Environmental Science0.5%
  • Agricultural and Biological Sciences0.2%
  • Computer Science0.1%
  • その他1%

トピック

  • Multiple Myeloma Research and Treatments14.8%
  • Antifungal resistance and susceptibility8.1%
  • Protein Degradation and Inhibitors7.2%
  • Fungal Infections and Studies6.2%
  • Acute Myeloid Leukemia Research5.7%
  • Peptidase Inhibition and Analysis4%
  • その他54%

共著者

全論文

検索で開く
  1. Bortezomib, thalidomide, and dexamethasone with or without daratumumab before and after autologous stem-cell transplantation for newly diagnosed multiple myeloma (CASSIOPEIA): a randomised, open-label, phase 3 study

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Soraya Wuillème, Sonja Zweegman, Brigitte Kolb, Cyrille Touzeau, Murielle Roussel, Mourad Tiab, Jean‐Pierre Marolleau, Nathalie Meuleman, Marie‐Christiane Vekemans, Matthijs Westerman, Saskia K. Klein, Mark‐David Levin, Jean Paul Fermand, Martine Escoffre‐Barbe, Jean‐Richard Eveillard, Réda Garidi, Tahamtan Ahmadi, Sen Hong Zhuang, Christopher Chiu, Lixia Pei, Carla de Boer, Elena Smith, William Deraedt, Tobias Kampfenkel, Jordan M. Schecter, Jessica Vermeulen, Hervé Avet‐Loiseau, Pieter Sonneveld - The Lancet 2019 被引用: 953

  2. Lenalidomide, Bortezomib, and Dexamethasone with Transplantation for Myeloma

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2017 被引用: 1,234

  3. Isatuximab plus pomalidomide and low-dose dexamethasone versus pomalidomide and low-dose dexamethasone in patients with relapsed and refractory multiple myeloma (ICARIA-MM): a randomised, multicentre, open-label, phase 3 study

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jeffrey Shang-Yi Huang, Jiří Minařík, Michèle Cavo, H. Miles Prince, Sandrine Macé, Kathryn P. Corzo, Frank Campana, Solenn Le-Guennec, Franck Dubin, Kenneth C. Anderson, Simon J. Harrison, Wojciech Janowski, Ian Kerridge, Andrew Spencer, Michel Delforge, Karel Fostier, Philip Vlummens, Ka Lung Wu, Richard LeBlanc, Michel Pavic, Michaël Sébag, Roman Hájek, Vladimír Maisnar, Luděk Pour, Henrik Gregersen, Lotfi Benbouker, Denis Caillot, Martine Escoffre‐Barbe, Thierry Façon, Laurent Frenzel, Cyrille Hulin, Lionel Karlin, Brigitte Kolb, Brigitte Pegourié, Aurore Perrot, Mourad Tiab, Laure Vincent, Dietger Niederwieser, Αchilles Anagnostopoulos, Sosana Delimpasi, Marie‐Christine Kyrtsonis, Anargyros Symeonidis, Árpád Illés, Gábor Mikala, Zsolt Nagy, Sara Bringen, Paolo Corradini, Fabio Ciceri, Roberto M. Lemoli, Anna Marina Liberati, Chiara Nozzoli, Renato Zambello, Shinsuke Iida, Takashi Ikeda, Satoshi Iyama, Morio Matsumoto, Chihiro Shimazaki, Kazutaka Sunami, Kenshi Suzuki, Michihiro Uchiyama, Youngil Koh, Kihyun Kım, Jae Hoon Lee, Chang‐Ki Min, Hillary Blacklock, Hugh J. B. Goodman, Annette Neylon, David Simpson, Sebastian Grosicki, Artur Jurczyszyn ほか 30 名 - The Lancet 2019 被引用: 636

  4. Voriconazole versus Amphotericin B for Primary Therapy of Invasive Aspergillosis

    著者: , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2002 被引用: 3,297

  5. Evaluation of Serum Mucorales Polymerase Chain Reaction (PCR) for the Diagnosis of Mucormycoses: The MODIMUCOR Prospective Trial

    著者: , , , , , , , , , , , , , , , , , , , , , - Clinical Infectious Diseases 2022 被引用: 174

  6. Postinduction Minimal Residual Disease Predicts Outcome and Benefit From Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia WithNPM1Mutation: A Study by the Acute Leukemia French Association Group

    著者: , , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2017 被引用: 292

  7. Maintenance with daratumumab or observation following treatment with bortezomib, thalidomide, and dexamethasone with or without daratumumab and autologous stem-cell transplant in patients with newly diagnosed multiple myeloma (CASSIOPEIA): an open-label, randomised, phase 3 trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Cyrille Touzeau, Mourad Tiab, Jean‐Pierre Marolleau, Nathalie Meuleman, Marie‐Christiane Vekemans, Matthijs Westerman, Saskia K. Klein, Mark‐David Levin, Fritz Offner, Martine Escoffre‐Barbe, Jean‐Richard Eveillard, Réda Garidi, Tahamtan Ahmadi, Maria Krevvata, Ke Zhang, Carla de Boer, Sanjay Vara, Tobias Kampfenkel, Véronique Vanquickelberghe, Jessica Vermeulen, Hervé Avet‐Loiseau, Pieter Sonneveld - The Lancet Oncology 2021 被引用: 175

  8. Gemtuzumab ozogamicin for de novo acute myeloid leukemia: final efficacy and safety updates from the open-label, phase III ALFA-0701 trial

    著者: , , , , , , , , , , , , , , , , - Haematologica 2018 被引用: 352

  9. Daratumumab plus lenalidomide and dexamethasone in transplant-ineligible newly diagnosed multiple myeloma: frailty subgroup analysis of MAIA

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Leukemia 2022 被引用: 123

  10. Lenalidomide Maintenance after Stem-Cell Transplantation for Multiple Myeloma

    著者: , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2012 被引用: 1,153

  11. Prospective Evaluation of Magnetic Resonance Imaging and [18F]Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography at Diagnosis and Before Maintenance Therapy in Symptomatic Patients With Multiple Myeloma Included in the IFM/DFCI 2009 Trial: Results of the IMAJEM Study

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2017 被引用: 320

  12. Standardization of 18F-FDG–PET/CT According to Deauville Criteria for Metabolic Complete Response Definition in Newly Diagnosed Multiple Myeloma

    著者: , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2020 被引用: 139

  13. Bortezomib, thalidomide, and dexamethasone with or without daratumumab and followed by daratumumab maintenance or observation in transplant-eligible newly diagnosed multiple myeloma: long-term follow-up of the CASSIOPEIA randomised controlled phase 3 trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jean‐Pierre Marolleau, Nathalie Meuleman, Marie‐Christiane Vekemans, Matthijs Westerman, Saskia K. Klein, Mark‐David Levin, Fritz Offner, Martine Escoffre‐Barbe, Jean‐Richard Eveillard, Réda Garidi, Winnie Hua, Jianping Wang, Alba Tuozzo, Carla de Boer, Melissa Rowe, Véronique Vanquickelberghe, Robin Carson, Jessica Vermeulen, Jill Corre, Pieter Sonneveld - The Lancet Oncology 2024 被引用: 112

  14. Genetic abnormalities and survival in multiple myeloma: the experience of the Intergroupe Francophone du Myelome

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Stéphane Minvielle, Jean‐Luc Harousseau, Thierry Façon, Claire Mathiot - Blood 2007 被引用: 905

  15. Impact of extramedullary disease in patients with newly diagnosed multiple myeloma undergoing autologous stem cell transplantation: a study from the Chronic Malignancies Working Party of the EBMT

    著者: , , , , , , , , , , , , , , , , , , , , , , , - Haematologica 2018 被引用: 112

  16. del(17p) without TP53 mutation confers a poor prognosis in intensively treated newly diagnosed patients with multiple myeloma

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , - Blood 2020 被引用: 87

  17. Active Surveillance Program to Increase Awareness on Invasive Fungal Diseases: the French RESSIF Network (2012 to 2018)

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Hervé Dupont, Julien Maizel, Anne Totet, Jean‐Philippe Bouchara, Anne Pauline Bellanger, Ana Berceanu, Jean Christophe Navellou, Émeline Scherer, Philippe Abboud, Christine Aznar, Denis Blanchet, Félix Djossou, Sophie Cayot, Cyril Garrouste, O. Lesens, Cécile Moluçon, Céline Nourrisson, Philippe Poirier, Éloïse Bailly, Louise Basmaciyan, Bouhemad Belaid, Mathieu Blot, Denis Caillot, Pierre‐Emmanuel Charles, Jean‐Pierre Quenot, E. Amazan, É. Baubion, André Cabie, Cyrille Chabartier, C. Deligny, Violaine Emal, Olivier Flechelle, Yves Hatchuel, Yohann Le Govic, H. Merle, Charline Miossec, Jean-Marie Turmel, Ruddy Valentino, Marie-Fleur Durieux, Pascal Turlure, Victor Mercier, M. Gari-Toussaint, Karine Risso, Loïc Simon, Cédric Bretonnière, David Boutoille, Thomas Gastinne, Karim Lakhal, É. Launay, Thierry Lepoivre, Pierre Péterlin, Fanny Rialland, Patrice Le Pape, Étienne Canouï, Naïma Dahane, Solène Kerneis, Cécile Angebault, M.-E. Bougnoux, Nadia Guennouni, Fanny Lanternier, Bennedicte Neven, Mehdi Oualha, Anne Scemla, Emilie Sitterlé, Felipe Suárez, Julie Toubiana, Stéphane Bonacorci, Alexandre Alanio, Anne Bergeron, Blandine Denis ほか 52 名 - mBio 2022 被引用: 98

  18. Early Versus Late Autologous Stem Cell Transplant in Newly Diagnosed Multiple Myeloma: Long-Term Follow-up Analysis of the IFM 2009 Trial

    著者: , , , , , , , , , , , , , , , , , , , , , - Blood 2020 被引用: 124

  19. CML Hematopoietic Stem Cells Expressing IL1RAP Can Be Targeted by Chimeric Antigen Receptor–Engineered T Cells

    著者: , , , , , , , , , , , , , , , , - Cancer Research 2018 被引用: 92

  20. Chimeric antigen receptor T-cells targeting IL-1RAP: a promising new cellular immunotherapy to treat acute myeloid leukemia

    著者: , , , , , , , , , , , , , , , , , , , , , , - Journal for ImmunoTherapy of Cancer 2022 被引用: 41

  21. Prognostic impact of translocation t(14;16) in multiple myeloma according to the presence of additional genetic lesions

    著者: , , , , , , , , , , , , , , , , , , , , , , , - Blood Cancer Journal 2023 被引用: 27

  22. Stem cell yield and transplantation in transplant-eligible newly diagnosed multiple myeloma patients receiving daratumumab + bortezomib/thalidomide/dexamethasone in the phase 3 CASSIOPEIA study

    著者: , , , , , , , , , , , , , , , , , , , , , , - Haematologica 2021 被引用: 52

  23. Single versus Double Autologous Stem-Cell Transplantation for Multiple Myeloma

    著者: , , , , , , , , , , , , , - New England Journal of Medicine 2003 被引用: 974

  24. Long-Term Analysis of the IFM 99 Trials for Myeloma: Cytogenetic Abnormalities [t(4;14), del(17p), 1q gains] Play a Major Role in Defining Long-Term Survival

    著者: , , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2012 被引用: 224